IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — VBIO

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022
Cash & Equivalents2.117.223.451.180.672.193.691.675.172.665.176.339.0510.80
Accounts Receivable----0.020.010.010.010.020.070.130.010.060.100.090.12
Inventory0.750.750.000.280.310.730.770.770.930.990.940.760.830.45
Total Current Assets3.388.653.741.841.263.164.662.836.464.006.487.5910.3712.00
Property, Plant & Equipment12.3412.640.010.120.120.120.120.120.120.120.100.020.010.02
Goodwill3.463.46------------------------
Intangible Assets2.242.242.24----------------------
Total Non-current Assets*29.0929.562.492.672.520.230.120.460.550.600.620.610.650.70
Total Assets32.4738.226.234.513.783.394.783.297.014.607.108.2111.0312.69
Accounts Payable0.640.630.470.230.440.330.450.550.640.831.091.601.920.63
Total Current Liabilities3.052.620.640.820.740.560.590.991.001.161.572.022.381.10
Total Non-current Liabilities*17.5417.050.000.000.000.000.000.140.240.280.320.410.460.50
Total Liabilities20.5919.670.640.820.740.560.591.131.241.441.902.442.841.60
Retained Earnings(66.51)(59.03)(49.62)(46.97)(45.04)(42.06)(40.63)(39.37)(35.64)(33.88)(31.76)(27.39)(24.80)(21.79)
Total Stockholder Equity4.2511.065.593.693.042.834.192.155.773.165.215.778.1911.09

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
Total Revenue------0.150.090.070.180.130.140.330.360.280.160.380.410.480.530.32
Cost of Revenue------0.290.030.020.420.080.110.170.350.170.100.260.370.410.400.30
Gross Profit------(0.14)0.050.05(0.24)0.040.030.170.010.110.060.110.040.060.130.02
Research & Development2.701.851.280.860.660.340.330.420.300.260.360.340.470.490.440.400.500.20
Selling, General & Admin3.723.78--1.070.911.040.730.820.730.891.151.051.271.281.361.761.520.58
Total Operating Expenses6.425.632.022.341.991.561.301.481.241.652.251.872.192.232.302.653.141.08
Operating Income(6.42)(5.63)(1.97)(2.48)(1.93)(1.51)(1.54)(1.43)(1.21)(1.48)(2.24)(1.76)(2.12)(2.12)(2.26)(2.58)(3.02)(1.06)
Interest Expense--------------------------------0.220.27
Pretax Income----------------------------------(1.36)
Net Income(7.10)(6.20)(2.85)(2.60)(1.93)(1.50)(1.48)(1.43)(1.27)(1.48)(2.24)(1.76)(2.12)(2.12)(2.25)(2.58)(3.02)(2.24)
Basic EPS(2.17)(2.23)(1.16)(1.97)(2.19)(2.52)(18.12)(0.23)(0.32)(1.01)(8.74)(1.48)(0.07)(0.11)(0.22)(0.27)(0.32)(0.23)
Diluted EPS--------(2.19)(2.52)(18.12)(0.23)(0.32)(1.01)(8.74)(1.48)(0.07)(0.11)(0.22)(0.27)(0.32)(0.58)

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
Operating Cash Flow(5.28)(5.01)(2.29)(2.00)(1.83)(0.89)(1.36)(1.41)(1.29)(1.67)(1.77)(1.87)(2.44)(2.43)(2.23)(2.77)(0.54)(0.66)
Capital Expenditures0.060.010.030.010.00----------0.000.000.020.090.000.010.000.01
Free Cash Flow*(5.34)(5.02)(2.31)(2.01)(1.83)----------(1.77)(1.87)(2.46)(2.52)(2.23)(2.78)(0.54)(0.67)
Investing Cash Flow(0.06)(0.01)(0.15)(0.01)(0.02)(0.53)--------0.000.00(0.02)(0.09)0.00-0.00(0.01)(0.01)
Financing Cash Flow0.23(0.04)11.634.272.360.081.18(0.10)3.31(0.06)0.004.38(0.04)4.17(0.58)0.871.570.22

* Derived from reported values